Emcure Pharmaceuticals Company Description

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.

It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names.

Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss.

Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Emcure Pharmaceuticals Limited

Country	India
Founded	1981
Industry	Pharmaceutical Preparations
Employees	6,731
CEO	Satish Mehta

Contact Details

Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India
Phone	91 20 3507 0033
Website	emcure.com

Stock Details

Ticker Symbol	544210
Exchange	Bombay Stock Exchange
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2834

Key Executives

Name	Position
Satish Mehta	Chief Executive Officer
Tajuddin Shaikh	Chief Financial Officer
Samit Mehta	Chief Operating Officer